Incidence and Predictors of Recurrent Sick Leave in Survivors Who Returned to Work after Allogeneic Hematopoietic Cell Transplantation.
Journal of cancer survivorship(2022)
摘要
Although rather favorable probabilities of return to work have been reported after allogeneic hematopoietic cell transplantation (allo-HCT), survivors often have difficulty continuing to work because of their immunocompromised status and diverse late effects after allo-HCT. We evaluated the incidence of and risk factors for recurrent sick leave in allo-HCT survivors after they initially returned to work. We targeted allo-HCT survivors who were employed at diagnosis, aged 20–64 at survey, and survived for ≥ 2 years without relapse. Of the 1904 survivors who were informed of the study, 1148 returned the questionnaire (60
更多查看译文
关键词
Allogeneic hematopoietic cell transplantation,Resignation,Return to work,Recurrent sick leave,Survivorship
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要